ECG equipment and management systems are devices that use electromagnetic waves to monitor heartbeats, which can then be displayed on an ECG panel. ECG equipment and management systems are being used to diagnose various cardiovascular and coronary diseases in patient, allowing for the most appropriate medical care. The ECG test is a safe, effective, and painless tool for determining cardiac discrepancy patterns. ECG devices determine how the heart is functioning in the body as it is subjected to some stimuli or activities. Incessant illness has become a significant cause of illnesses and diseases all over the globe, putting a lot of emphasis on the healthcare sector to follow a modern paradigm of medical evaluation and improved medical services, raising investment in new inventions in ECG equipment and management systems.
Market Dynamics
Cardiac monitoring is one of the most reliable and efficient options for monitoring various cardiac conditions. Various advancements, product approvals and launches, partnerships, and acquisitions by the key market players in cardiac monitoring devices are likely to boost the growth of the studied market over the forecast period. For instance, in August 2022, Merit Medical Systems, Inc. is a manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures in U.S., launched the SafeGuard Focus Cool Compression Device, an innovative addition to its SafeGuard platform. It is a component of a more extensive cardiac portfolio that also includes the tools and accessories required for interventional cardiac resynchronization therapy, electrophysiology, and management of cardiac rhythm. Moreover, in February 2022, Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States, launched one of the first patient implants of a dual-chamber leadless pacemaker system as part of its AVEIR DR i2i pivotal clinical study. The implant of Abbott's investigational Aveir dual-chamber leadless pacemaker took place globally within the crucial study and marks a significant technological milestone for leadless pacing technology. Also, in November 2020, VitalConnect, Inc., a developer of remote and in-hospital wearable biosensor technology, launched its VitalPatch RTM cardiac monitoring solution. VitalPatch RTM monitors for 21 cardiac arrhythmias through a unique Artificial Intelegnce-based ECG analysis solution and captures data on four key vital signs, providing a thorough understanding of a patient's state.
Key features of the study:
Detailed Segmentation:
Detailed Segmentation:
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients